Evidence map›Paper›PMID 40423347›Full record

ArticleTropical medicine and infectious disease2025

Secondary Metabolites from a New Antibiotic-Producing Endophytic Streptomyces Isolate Inhibited Pathogenic and Multidrug-Resistant

Govinda Raju Vadankula, Arshad Rizvi, Haider Ali, Rakhi Khunjamayum, V V Ramprasad Eedara, Vijay Nema, Debananda Singh Ningthoujam, Katragadda Suresh Babu, Prakasham Reddy Shetty, Shekhar C Mande and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Govinda Raju VadankulaLaboratory of Molecular Pathogenesis, Department of Biochemistry, School of Life Sciences, University of Hyderabad (UoH), Hyderabad 500046, India.ORCID 0009-0002-1378-8362
Arshad RizviLaboratory of Molecular Pathogenesis, Department of Biochemistry, School of Life Sciences, University of Hyderabad (UoH), Hyderabad 500046, India.ORCID 0000-0003-4043-7381
Haider AliLaboratory of Molecular Pathogenesis, Department of Biochemistry, School of Life Sciences, University of Hyderabad (UoH), Hyderabad 500046, India.ORCID 0000-0003-1618-8469
Rakhi KhunjamayumMicrobial Biotechnology Research Laboratory (MBRL), Department of Biochemistry, Manipur University, Canchipur 795003, India.ORCID 0009-0005-5952-6319
V V Ramprasad EedaraMNR Medical College and Hospital, MNR Nagar, Fasalwadi, Narsapur Road, Sanga Reddy, Hyderabad 502294, India.ORCID 0000-0002-3950-3858
Vijay NemaMolecular Biology Division, National Institute of Translational Virology and AIDS Research (Formerly National AIDS Research Institute), Pune 411026, India.ORCID 0000-0001-6420-9397
Debananda Singh NingthoujamMicrobial Biotechnology Research Laboratory (MBRL), Department of Biochemistry, Manipur University, Canchipur 795003, India.
Katragadda Suresh BabuCentre for Natural Products and Traditional Knowledge, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India.
Prakasham Reddy ShettyMedicinal Chemistry and Biotechnology Lab- Organic Synthesis and Process Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India.
Shekhar C MandeNational Centre for Cell Science, Pune 411007, India.
Sharmistha BanerjeeLaboratory of Molecular Pathogenesis, Department of Biochemistry, School of Life Sciences, University of Hyderabad (UoH), Hyderabad 500046, India.

Funding

DBT BT/PR25395/NER/95/1177/2017DST-BRICS DST/ICDBRICS/PilotCall2/MRP-TB (G)IoE RC4-21-012
6 · The paper itself

Abstract

The long regimen of drug therapy, the emergence of drug-resistance (DR), and infections with non-tuberculous mycobacteria (NTMs) are alarming challenges in controlling tuberculosis (TB), a disease caused by

Indexed as

actinomycetesantibioticsanti-M.tb activityLC-MSMDR-TBtuberculosis

Identifiers

PMID40423347
PMCPMC12115879

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.